SANGUEDOLCE, Rosario
SANGUEDOLCE, Rosario
Biopatologia e Biotecnologie Mediche (attivo dal 01/01/2010 al 31/12/2018)
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”.
2006-01-01 POMA P; NOTARBARTOLO DI VILLAROSA, M; LABBOZZETTA M; SANGUEDOLCE R; ALAIMO A; CARINA V; MAURICI A; CUSIMANO A; CERVELLO M; D'ALESSANDRO N
Analysis of coding and non-coding regions of thymidylate syntetase gene in colorectal cancer patients and its possible relationship with 5-fluorouracil drug response
2007-01-01 CALASCIBETTA A; GULOTTA G; CAJOZZO M; FEO S; AGRUSA A; GANGUEDOLCE G; SANGUEDOLCE R
Analysis of the thymidylate syntethase gene structure in colorectal cancer patients, and its possible relation with the 5-fluoruracil drug response
2007-01-01 SANGUEDOLCE R; GULOTTA G; CAJOZZO M; AGRUSA A; FESO S; SANGUEDOLCE G; CALASCIBETTA A
Analysis of the Thymidylate Synthase Gene Structure in Colorectal Cancer Patients and lts Possible Relation with the S-Fluorouracil Drug Response
2010-01-01 Calascibetta, A; Contino, F; Feo, S; Gulotta, G; Cajozzo, M; Antona, A; Sanguedolce, G; Sanguedolce, R
Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer
2004-01-01 MERKELBACH BRUSE, S; HANS, V; MATHIAK, M; SANGUEDOLCE, R; ALESSANDRO, R; RUSCHOFF J; BUTTNER, R; HOUSHDARAN, F; GULLOTTI, L
Clinical relevance of thymidylate syntetase expression in the signet ring cell histotype component of colorectal carcinoma
2004-01-01 CABIBI, D; CALASCIBETTA, A; CAMPIONE, M; BARRESI, E; RAUSA, L; DARDANONI, G; ARAGONA, F; SANGUEDOLCE, R
Correlation between GP-170 expression, prognosis, and chemoresistance of superficial bladder carcinoma
2003-01-01 Serretta, V; Pavone, C; Allegro, R; Vella, M; Sanguedolce, R; Porcasi, R; Morello, V; Tomasino, RM; Pavone, M
Could a variant structural form of thymidylate synthase gene of metastatic colorectal cancer patients be related with the poor response to 5 Fu treatment?
2008-01-01 CALASCIBETTA A; GGULOTTA; G DIANA; G GUERCIO; G SANGUEDOLCE; R SANGUEDOLCE
Decreased expression of thymidylate synthase and low proliferation index assessed by ki67 in " signet ring cell component" of colorectal carcinomas
2006-01-01 CABIBI D; CALASCIBETTA A; CAMPIONE F; ARAGONA F; SANGUEDOLCE R
Decreased expression of thymidylate synthase and low proliferation index by Ki67 in "signet ring cell component of colorectal carcinoma"
2007-01-01 D CABIBI; A CALASCIBETTA; M CAMPIONE; SANGUEDOLCE R
Difference in ki67 and Thimidylate Synthase expressin in primary tumour compared with metastatic nodes in breast cancer patients
2006-01-01 CALASCIBETTA A; CABIBI D; RAUSA L; ARAGONA F; BARRESI E; MARTORANA A; SANGUEDOLCE R
Difference in ki67 and thymidylate synthase expression in primary tumour compared with metastastic nodes in breast cancer patients
2005-01-01 CALASCIBETTA A; CABIBI D; RAUSA L; ARAGONA F; BARRESE E; MARTORANA A; SANGUEDOLCE R
Difference in ki67 and thymidylate synthase expression in primary tumour compared with metastastic nodes in breast cancer patients. european society for the study of purine and pyrimidine metabolism in man
2005-01-01 CALASCIBETTA A; RAUSA L; CABIBI D; ARAGONA F; BARRESI E; MARTORANA A; SANGUEDOLCE R
Difference in Ki67 and Thymidylate synthase expression in primary tumour compared with metastatic nodes in breast cancer patients
2005-01-01 RAUSA L; CALASCIBETTA A; CABIBI D; ARAGONA F; BARRESI E; MARTORANA A; SANGUEDOLCE R
Difference in Ki67 and thymidylate synthase expression in primary tumour compared with metastatic nodes in breast cancer patients.
2006-01-01 CALASCIBETTA A; CABIBI D; RAUSA L; ARAGONA F; BARRESI E; MARTORANA A; SANGUEDOLCE R
DIFFERENCE IN KI67 AND THYMIDYLATE SYNTHASE, P53 LEVELS AND THE TREATMENT BY CMF DRUG COMBINATION VERSUS TAXANES IN THE LOCALLY ADVANCED CARCINOMA OF THE BREAST
2005-01-01 SANGUEDOLCE R; RAUSAL; CABIBI D; ARAGONA F; BARRESI E; MARTORANA A CALASCIBETTA A
DIFFERENT EXPRESSION OF E-CADERINE, BETA CATENIN AND FIBRONECTIN IN SIGNET RING CELL AND INTESTINAL CARCINOMA.
2006-01-01 SANGUEDOLCE R; D CABIBI; L RAUSA; F FERRAU'; F ARAGONA; A MARTORANA; E BARRESI; A CALASCIBETTA
Different expression of e-cadherin, beta-catenin and fibronectin in signet ring cell, and intestinal colorectal carcinoma
2006-01-01 SANGUEDOLCE R; CABIBI D; RAUSA L; FEARRU F; ARAGONA F; MARTORANA A; BARRESI E; CALASCIBETTA A
DIFFERENT EXPRESSION OF E-CADHERINE, BETA-CATENIN, AND FIBRONECTIN IN SIGNET RING CELL AND INTESTINAL COLORECTAL CARCINOMA.
2006-01-01 SANGUEDOLCE R; CABIBI D; RAUSA L; FERRA F; ARAGONA F; MARTORANA A; BARRESI E; CALASCIBETTA A
Different expression of thymidylate synthase in primary tumour and metastatic nodes in breast cancer patients.
2007-01-01 CABIBI D; CALASCIBETTA A; MARTORANA A; CAMPIONE M; BARRESI E; RAUSA L; ARAGONA F; SANGUEDOLCE R